InnoCan Secures FDA CVM Waiver for LPT-CBD Drug
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
HERZLIYA, Israel and CALGARY, Canada, February 27, 2026 InnoCan Pharma Corporation announced that the U.S. FDA Center for Veterinary...
RAHWAY, N.J., March 2026 Merck Animal Health announced that the U.S. Food and Drug Administration (FDA) has approved BRAVECTO®...
Indianapolis, USA | January 22, 2026 — Elanco Animal Health, a global leader in veterinary pharmaceuticals and animal health...
DULUTH, Georgia | January 19, 2026 — Boehringer Ingelheim announced that the U.S. Food and Drug Administration has granted...
